2 studies found for:    20818844 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of the Combination Vemurafenib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Peg-interferon
2 Active, not recruiting Safety Study of PLX4032 in Patients With Solid Tumors
Conditions: Malignant Melanoma;   Colorectal Carcinoma
Intervention: Drug: PLX4032

Indicates status has not been verified in more than two years